Clinical Trials Browser

Enoxaparin × Classical hematology × Clear all

Thrombocytopenia

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4 Enrolling by invitation

2,868 enrolled

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01583218 2023-08-07

APEX

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2 Completed

400 enrolled 16 charts

Classical hematology

Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Phase 2 Terminated

2 enrolled

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Completed

4,068 enrolled

Classical hematology

Venous Thrombosis, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

56 enrolled

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00723216 2010-04-05

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Phase 3 Completed

151 enrolled

Classical hematology

Abdominal Neoplasms, Venous Thromboembolism

Clinical Trials

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

CANVAS

APEX

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

ALICAT

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Longheva

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery